carbostyril has been researched along with Kidney Diseases in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Huyan, T; Li, X; Liu, Q; Shi, Y; Su, J; Tie, L; Wang, D; Wang, Q; Wang, Y; Zhang, F; Zou, X | 1 |
| Edelman, A; Gauthier, S; Guerrera, IC; Hinzpeter, A; Jung, V; Martignetti, L; Nguyen-Khoa, T; Pranke, I; Semeraro, M; Sermet-Gaudelus, I; Stoven, V | 1 |
| Bullins, KW; Denham, JW; Hanley, AV; Hanley, GA; Harirforoosh, S; Panus, PC; Wood, RC; Wyatt, JE | 1 |
| Akahoshi, Y; Fujiki, H; Ikeda, T; Iwanaga, Y; Miyazaki, S; Morooka, H; Watanabe, H | 1 |
| Boulton, DW; Bramer, SL; Mallikaarjun, S; Shoaf, SE | 1 |
| Boucek, P; Honsova, E; Lodererova, A; Slatinska, J | 1 |
| Bramer, SL; Kitani, M; Miyamoto, G; Tammara, B; Trang, JM | 1 |
| Chandraker, A; Josephson, MA; Randhawa, PS; Williams, JW | 1 |
| Kinoshita, Y; Miki, A; Nagasaki, Y; Ohtani, H; Sata, H; Sawada, Y; Tsujimoto, M | 1 |
| Ishibashi, Y; Nogita, T; Shimada, J | 1 |
| Bramer, SL; Efthymiopoulos, C; Gambertoglio, JG; Maroli, A | 1 |
| Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA | 1 |
| Marstein, S; Nilsen, OG; Saltvedt, E; Walstad, RA | 1 |
| Feistauer, SM; Georgopoulos, A; Georgopoulos, M; Graninger, W; Pfleger, S | 1 |
| Coffey, AK; Dousa, TP; Homma, S; O'Sullivan, DJ; Valtin, H | 1 |
| Pernet, AG | 1 |
| Kinzig, M; Mahr, G; Muth, P; Naber, KG; Sorgel, F | 1 |
| Braeckman, R; Craft, JC; Granneman, GR; Kraut, J; Shupien, S | 1 |
| Blum, RA; Schentag, JJ; Schultz, RW | 1 |
3 review(s) available for carbostyril and Kidney Diseases
| Article | Year |
|---|---|
Polyomavirus-associated nephropathy: update on antiviral strategies.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Organophosphonates; Polyomavirus; Polyomavirus Infections; Quinolones | 2006 |
Clinical pharmacokinetics of sparfloxacin.
Topics: Aging; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Japan; Kidney Diseases; Quinolones | 1993 |
Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
Topics: Aging; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Kidney Diseases; Liver Diseases; Quinolones; Tissue Distribution | 1991 |
2 trial(s) available for carbostyril and Kidney Diseases
| Article | Year |
|---|---|
Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole.
Topics: Adult; Aged; Antipsychotic Agents; Area Under Curve; Aripiprazole; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Piperazines; Protein Binding; Quinolones; Severity of Illness Index | 2008 |
The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment.
Topics: Adult; Aged; Cardiotonic Agents; Chromatography, High Pressure Liquid; Female; Heart Failure; Humans; Indicators and Reagents; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Middle Aged; Quinolones; Reproducibility of Results; Time Factors | 2002 |
14 other study(ies) available for carbostyril and Kidney Diseases
| Article | Year |
|---|---|
FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis.
Topics: Animals; Apoptosis; Cell Line; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Forkhead Box Protein O1; Humans; Kidney Diseases; Kidney Tubules; Male; Mice, Inbred C57BL; Mitochondria; Mitophagy; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Quinolones; Reperfusion Injury; Signal Transduction | 2020 |
Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Drug Combinations; Exosomes; Humans; Indoles; Kidney Diseases; Proteome; Quinolones; Young Adult | 2020 |
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cell Adhesion Molecules; Creatinine; Diclofenac; Dinoprostone; Drug Interactions; Kidney; Kidney Diseases; Male; Nitric Oxide; Potassium; Pyrazoles; Quinolones; Rats; Rats, Sprague-Dawley; Sodium; Sulfonamides | 2013 |
Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Male; Piperidines; Quinolones; Rats, Inbred Dahl; Receptors, Vasopressin; Time Factors; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Cured malakoplakia of the renal allograft followed by long-term good function: a case report.
Topics: Adult; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Female; Humans; Kidney Diseases; Kidney Transplantation; Malacoplakia; Pancreas Transplantation; Quinolones | 2012 |
Dosage adjustment of quinolone antibiotics and angiotensin-converting enzyme inhibitors in patients with renal dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Creatinine; Humans; Kidney Diseases; Quinolones | 2006 |
Effect of renal impairment on the pharmacokinetics of grepafloxacin.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Creatinine; Female; Fluoroquinolones; Humans; Kidney Diseases; Male; Middle Aged; Piperazines; Quinolones | 1997 |
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 1998 |
Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
Topics: Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Creatinine; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Kidney; Kidney Diseases; Linear Models; Male; Middle Aged; Quinolones | 1992 |
Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Topics: Abscess; Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Fluoroquinolones; Half-Life; Kidney Diseases; Methicillin Resistance; Mice; Quinolones; Staphylococcal Infections | 1992 |
Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Membrane; Cyclic AMP; Diabetes Insipidus; Freeze Fracturing; Isoenzymes; Kidney Diseases; Mice; Mice, Mutant Strains; Microscopy, Electron; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinolones; Rolipram | 1991 |
Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
Topics: Age Factors; Aged; Anti-Infective Agents; Bacterial Infections; Drug Interactions; Female; Fluoroquinolones; Humans; Kidney Diseases; Male; Quinolones; Risk Factors; Sex Factors | 1991 |
Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
Topics: Adult; Aged; Anti-Infective Agents; Fluoroquinolones; Half-Life; Humans; Kidney Diseases; Male; Middle Aged; Quinolones; Renal Dialysis; Tissue Distribution | 1991 |
Pharmacokinetics of lomefloxacin in renally compromised patients.
Topics: 4-Quinolones; Anti-Infective Agents; Female; Fluoroquinolones; Glucuronates; Half-Life; Humans; Kidney Diseases; Male; Quinolones; Renal Dialysis | 1990 |